Fulgent Genetics (FLGT) Cash from Operations (2015 - 2026)

Fulgent Genetics has reported Cash from Operations for 12 years, with the latest figure at 23758000.0 in Q2 2026.

• Quarterly Cash from Operations rose 21.26% year-over-year to 23758000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 83697000.0 (down 233.55% YoY) and the FY2025 annual result came in at 101638000.0, down 582.61% from the prior year.
• Cash from Operations eased to 23758000.0 in Q2 2026 per FLGT's latest filing, from 7097000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 188411000.0 in Q1 2022 and troughed at 78143000.0 in Q4 2025.
• A 5-year average of 10182444.44 and a median of 8501500.0 in 2023 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2025 and 2026: Cash from Operations slumped 804.11% in 2025, then soared 260.17% in 2026.
• Over 5 years, Cash from Operations stood at 33207000.0 in 2022, then plunged by 55.03% to 14933000.0 in 2023, then jumped by 67.53% to 25018000.0 in 2024, then plunged by 412.35% to 78143000.0 in 2025, then soared by 69.6% to 23758000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 23758000.0, 7097000.0, and 78143000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.